|
Agent Type:
|
Semisynthetic;
|
|
Spectrum of activity:
|
Gram-positive & Antimycobacterial
|
|
Mechanism of action:
|
Unknown
|
|
Target Pathogen:
|
Active against Staphylococcus aureus and Mycobacterium tuberculosis
|
|
Description:
|
Semisynthetic compound based on natural product from venom of scorpion Diplocentrus melici with with benzoquinone scaffold; non-cytotoxicity observed in lung adenocarcinoma cell line (cytotoxic to T-cell leukemia, rhabdomyosarcoma, and metastatic neuroblastoma cell lines); at >100 ug/ml no erythrocyte haemolysis
|
|
Institute where first reported:
|
Department of Molecular Medicine and Bioprocesses, Instituto de Biotecnologia, Universidad Nacional Autonoma de Mexico; Department of Chemistry, Stanford University, Stanford, CA;
|
|
Year first mentioned:
|
2019
|
|
Development status:
|
Experimental
|